rct
    2012
    High Quality

    A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis

    Wolosker N, de Campos JR, Kauffman P, Puech-Leao P

    Published in Journal of Vascular Surgery

    Key Findings

    Oxybutynin produced greater improvement in sweating and quality of life than placebo, with dry mouth as the main adverse effect.

    Conclusions

    Low-dose oral oxybutynin is an effective systemic option for hyperhidrosis.

    Limitations

    Single centre, 6-week duration.

    Related Health Concerns

    Excessive Sweating
    Dry Mouth

    Study Details

    Year:2012
    Sample Size:50
    Duration:6 weeks
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.